STELLAR BIOTECHNOLOGIES INC Chart calendar Stellar Biotechnologies Inc
250608d8eca6b18c1a30c8742094e.nOJaceooYlHEN99zEhRgMqAEKomahpxrTGZhJ3qQSNg.q7ZsHoAYJgL9RbIwS30yA-NoYdH5y9cPE14QQizTPp_SuztBsBo0ZPN7hg~0c2ab2870bfe03ab4f80a9fb57d46a14
Upcoming events on Stellar Biotechnologies Inc
Past events on Stellar Biotechnologies Inc
| Today | RBC Capital Markets Global Healthcare Conference |
| 10/05/2024 21:15 | Q2 2024 Earnings Release |
| 29/04/2024 16:30 | LSX World Congress |
| 17/04/2024 16:00 | Bloom Burton & Co. Healthcare Investor Conference |
| 14/04/2024 | Mintz Conference |
| 27/03/2024 | H.C. Wainwright Autoimmune & Inflammatory Disease Virtual Conference |
| 17/03/2024 | BioEurope Spring Conference |
| 11/03/2024 | Barclays Global Healthcare Conference |
| 07/03/2024 | American Academy of Dermatology Meeting |
| 06/03/2024 | American Contact Dermatitis Society Meeting |
| 09/02/2024 21:15 | Q1 2024 Earnings Release |
| 07/01/2024 | JPMorgan Healthcare Conference |
| 15/12/2023 21:10 | Q4 2023 Earnings Release |
| 05/11/2023 | Bio-Europe Conference |
| 01/11/2023 18:10 | Dermatology Drug Development Summit |
| 10/09/2023 | H.C. Wainwright Global Investment Conference |
| 10/08/2023 17:00 | Canaccord Genuity Growth Conference |
| 09/08/2023 21:15 | Q3 2023 Earnings Release |
| 04/06/2023 | BIO International Convention |
| 23/05/2023 15:30 | Annual General Meeting |
Annual results
| Fiscal Period | September | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,33 0,31 5.98% | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | -23,6 -12,0 -96.35% | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -6,40 -6,54 2.12% | -23,7 -24,4 2.98% | -18,4 -21,9 16.12% | -9,22 -9,03 -2.11% | -8,90 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -6,36 -6,10 -4.32% | -13,3 -15,5 13.83% | -17,5 -20,9 15.84% | -8,37 -8,84 5.24% | -8,63 |
|
Net income Million USD | Released Forecast Spread | -6,36 -6,10 -4.33% | -13,3 -15,5 13.82% | -17,5 -20,9 15.83% | -8,37 -8,85 5.32% | -8,63 |
|
EPS USD | Released Forecast Spread | -5,18 -4,90 -5.71% | -7,70 -8,38 8.08% | -7,35 -10,0 26.83% | -2,93 -3,09 5.18% | -2,32 |
| Announcement Date | 07/12/20 | 28/12/21 | 16/12/22 | 15/12/23 | - |
Quarterly results
| Fiscal Period | September | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -4,58 -5,44 15.9% | -5,80 -6,60 12.16% | -2,84 -6,40 55.68% | -2,38 -3,55 33.01% | -2,41 -3,32 27.32% | -2,06 -3,55 41.8% | -2,37 -2,13 -11.08% | -1,86 -3,80 51.12% | -2,22 -2,25 1.31% | -2,35 | -2,40 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -4,57 -5,27 13.35% | -5,79 -6,60 12.32% | -2,81 -6,15 54.25% | -2,33 -3,55 34.23% | -2,33 -3,31 29.54% | -1,98 -3,54 43.96% | -1,72 -2,13 19.17% | -1,68 -3,68 54.33% | -1,86 -2,17 14.26% | -2,19 | -2,57 |
|
Net income Million USD | Released Forecast Spread | -4,57 -5,27 13.33% | -5,79 -6,60 12.32% | -2,81 -6,15 54.25% | -2,33 -3,55 34.23% | -2,33 -3,31 29.51% | -1,98 -3,54 43.96% | -1,72 -2,13 19.17% | -1,68 -3,68 54.33% | -1,86 -2,17 14.22% | -2,19 | -2,57 |
|
EPS USD | Released Forecast Spread | -2,31 -2,57 10% | -2,59 -3,01 13.95% | -0,07 -2,77 97.47% | -0,91 -1,33 31.58% | -0,84 -1,21 30.77% | -0,70 -1,21 42.31% | -0,48 -0,72 32.87% | -0,54 -1,21 55.37% | -0,58 -0,69 16.35% | -0,52 | -0,62 |
| Announcement Date | 13/05/22 | 12/08/22 | 16/12/22 | 10/02/23 | 11/05/23 | 09/08/23 | 15/12/23 | 09/02/24 | 10/05/24 | - | - |
| 14/05/2024 | CELCUITY INC.: Q1 2024 Earnings Release |
| 15/05/2024 | BIOCON LIMITED: Q4 2024 Earnings Release |
| 16/05/2024 14:00 | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
| 17/05/2024 12:00 | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
| 23/07/2024 | VIKING THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected) |
| 24/07/2024 | BIOCON LIMITED: Q1 2025 Earnings Release (Projected) |
| 25/07/2024 06:00 | ARGENX SE: Q2 2024 Earnings Release |
| 29/07/2024 | RHYTHM PHARMACEUTICALS, INC.: Q2 2024 Earnings Release (Projected) |
| 29/07/2024 | NEUROCRINE BIOSCIENCES, INC.: Q2 2024 Earnings Release (Projected) |
| 29/07/2024 | CEREVEL THERAPEUTICS HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
